Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111276 · ClinicalTrials.gov registry record · NA
In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness
A NA study, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04111276: Completed NA study, sponsored by The University of Tennessee, Knoxville.
NCT04111276 is a NA study that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04111276, a NA study, has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement; this is the location from which participants will be recruited. The objective of this study will be to analyze subjects with symptomatic unicompartmental osteoarthritis under in vivo dynamic, weight-bearing conditions using video fluoroscopy to determine if present-day OA knee braces provide separation of the femoral condyle from the tibial plateau, thus avoiding excessive loads on the degenerative compartment.
Primary Outcome
Medial condylar separation during gait
Interventions
- DEVICE Breg Osteoarthritis Brace gait fluoroscopy
- OTHER Gait fluoroscopy without brace
- DIAGNOSTIC_TEST JointVue ultrasound
- DIAGNOSTIC_TEST Computer Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-07-12 |
| Est. Completion | 2020-11-06 |
| Phase | NA |
What the finished NCT04111276 record still lists
NCT04111276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Breg Osteoarthritis Brace gait fluoroscopy is the first listed.
NCT04111276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04111276 about?
NCT04111276 is a clinical study titled "In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness". In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement; this is the location from which participants will be recruited. The objective of this study will be...
What is the current status of trial NCT04111276?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-07-12. Estimated completion is 2020-11-06.
What interventions are being tested in trial NCT04111276?
The interventions under investigation include: Breg Osteoarthritis Brace gait fluoroscopy (DEVICE), Gait fluoroscopy without brace (OTHER), JointVue ultrasound (DIAGNOSTIC_TEST), Computer Tomography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04111276?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04111276's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI